News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Obesity affects breast cancer treatment

Obesity affects breast cancer treatment


Obesity may affect a common drug that is used as part of the treatment to fight breast cancer in post-menopausal women.

Obesity is now defined as a global pandemic and it’s predicted that more than half of the world’s population will be obese by 2030. Obesity is associated with an increased risk of several cancers and poorer outcomes for cancers such as colon, endometrial and post-menopausal breast cancer.

Aromatase inhibitors stop the production of oestrogen in post-menopausal women by blocking the enzyme aromatase, which turns the hormone androgen into small amounts of oestrogen in the body. This means that less oestrogen is available to stimulate the growth of hormone-receptor-positive breast cancer cells.

Aromatase inhibitors (AIs) can't stop the ovaries from making oestrogen, so aromatase inhibitors only work in postmenopausal women.

There are three types of aromatase inhibitors, and each one is a pill, usually taken once a day. It’s considered the best hormonal therapy to start with when treating early-stage, hormone-receptor-positive breast cancer.

“AIs may be less effective in obese women due to the greater quantity of aromatase in peripheral fatty tissue”, says study author, Professor Mark Elwood, an expert in cancer epidemiology from the University of Auckland.

That was one of the conclusions from his recent systematic review of eight earlier studies to assess the effect of obesity on AI efficacy in breast cancer treatment.

Studies included were interventional or observational studies with comparison groups of post-menopausal women with hormone receptor-positive breast cancer on treatment with an AI – alone or in combination with other drugs in which body mass index or another measure of obesity was used.

“Outcome measures included overall survival, disease-free survival or time to progressive disease, survival from the start of therapy, mortality measures, local or distant recurrence of primary cancer and time to recurrence,” says co-author, medical oncologist, Dr David Porter. “The systematic review showed a trend towards a negative effect of obesity on AI efficacy, but the size of the effect (in post-menopausal hormone receptor positive breast cancer), and whether it is the same with all AIs is difficult to determine.”

More information is needed before clinical recommendations are made, he says.

“AIs are prescribed at a fixed dose in all patients, but the apparent decreased efficacy in heavier patients warrants investigation of whether higher doses would be more effective in obese women,” says Dr Porter.

“It is important for physicians to contemplate more individualised treatment choices to limit the number of non-responders to treatment and to improve the likelihood of successful therapy for all patients,” he says.

“Many questions remain unanswered in this complex scenario and information is needed before recommendations for the improved use of AIs for obese patients could or should be made,” says Professor Elwood.

“Further evidence on the differing potencies of the major AIs in obesity would help clarify whether specific AIs may yield a better outcome in obese patients or whether prescribing higher doses of AIs might be useful.”

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Scoop Review Of Books: From Here And There

Being Chinese: A New Zealander’s Story
by Helene Wong.
This is the fascinating story of Helene Wong, born in 1949 in Taihape to Chinese parents: her mother, born soon after her parents migrated here, and her father, born in China but sent to relatives in Taihape at seven to get an education in English. More>>

Chiku: Hamilton Zoo's Baby Chimpanzee Named

Hamilton Zoo has named its three-month-old baby chimpanzee after a month-long public naming competition through the popular zoo’s website. The name chosen is Chiku, a Swahili name for girls meaning "talker" or "one who chatters". More>>

Game Over: Trans-Tasman Netball League To Discontinue

Netball Australia and Netball New Zealand have confirmed that the existing ANZ Championship format will discontinue after the current 2016 season, with both organisations to form national netball leagues in their respective countries. More>>

NZSO Review: Stephen Hough Is Perfection-Plus

He took risks, and leant into the music when required. But you also felt that every moment of his playing made sense in the wider picture of the piece. Playing alongside him, the NZSO were wonderful as ever, and their guest conductor, Gustavo Gimeno, coaxed from them a slightly darker, edgier sound than I’m used to hearing. More>>

ALSO:

Howard Davis Review: King Lear At Circa

In order to celebrate it's 40th birthday, it is perhaps fitting that Circa Theatre should pick a production of 'King Lear,' since it's also somewhat fortuitously Shakespeare's 400th anniversary. If some of the more cerebral poetry is lost in Michael Hurst's streamlined, full throttle production, it's more than made up for by plenty of lascivious violence designed to entertain the groundlings. More>>

Scoop Review Of Books: Tauranga Books Festival

Escape to Tauranga for Queen’s Birthday weekend and an ideas and books-focused festival that includes performance, discussion, story-telling, workshops and an Italian-theme morning tea. More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news